Latest News

HIV diagnosis at home and same-day ART start tied to better outcomes


 

REPORTING FROM CROI

– Diagnosing HIV infections in the home and starting persons who tested positive on antiretroviral therapy on the same day significantly increased the likelihood that the HIV-positive individuals would show up at a clinic for care within 3 months of diagnosis. It also improved their odds for having viral suppression at 12 months, compared with those who tested positive but were referred to a clinic for starting ART therapy, the standard of care.

Among 278 residents of the southern African nation of Lesotho, 68.8% of those randomized to an intervention in which they were offered same-day, home-based ART initiation and were given a 30-day supply of medication had linked to care by 3 months of follow-up, compared with 43.1% of those who were diagnosed and then referred to a health care facility to be started on ART, reported Niklaus D. Labhardt, MD, from the Swiss Tropical and Public Health Institute in Basel, and his colleagues.

Dr. Niklaus D. Labhardt Neil Osterweil, Frontline Medical News

Dr. Niklaus D. Labhardt

At 12 months, rates of viral suppression were 50.4% in the same-day ART group, compared with 34.3% in the standard-of-care group, he said at the annual Conference on Retroviruses and Opportunistic Infections.

“This easy addition to the current practice of home-based testing has the potential to improve practice sub-Saharan African when it will become part of future guidelines and policies,” he said at a media briefing following his presentation of the data in an oral abstract session.

Pages

Recommended Reading

State regulations for tattoo facilities increased blood donor pools
Federal Practitioner
Boston VA Medical Forum: HIV-Positive Veteran With Progressive Visual Changes
Federal Practitioner
Introducing the VA Boston Medical Forum
Federal Practitioner
Monitoring HIV and Kidney Disease in Aging Asians
Federal Practitioner
Reducing the Stigma of HIV Testing With Online Support
Federal Practitioner
Clinical Trial Begins for Long-Acting Anti-HIV Injectable
Federal Practitioner
Closing the Timing Gap Between HIV Infection and Diagnosis
Federal Practitioner
HIV Treatment: OK to Take a Break?
Federal Practitioner
Large-vessel vasculitis: More severe in HIV-infected patients
Federal Practitioner
Inflammatory markers predict vaccine response in HCV, HIV
Federal Practitioner